Model-based analysis of thromboxane B₂ and prostaglandin E₂ as biomarkers in the safety evaluation of naproxen.

No abstract is available for this paper.

• Publication year

  2014

• Venue

  Toxicology and Applied Pharmacology

• Publication date

  2014-08-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1016/j.taap.2014.03.010PMID 24667227
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Systems pharmacology modeling: an approach to improving drug safety.

  2014cited by this paper
• Mechanisms of Adverse Drug Reactions

  2014cited by this paper
• Identifying the translational gap in the evaluation of drug-induced QTc interval prolongation.

  2013cited by this paper
• Systems pharmacology to predict drug toxicity: integration across levels of biological organization.

  2013cited by this paper
• Progress in Using Systematic Reviews of Animal Studies to Improve Translational Research

  2013cited by this paper
• Reducing safety-related drug attrition: the use of in vitro pharmacological profiling

  2012cited by this paper
• Evaluation of IPPSE, an alternative method for sequential population PKPD analysis

  2012cited by this paper
• Toxicological screening

  2011cited by this paper
• Role of systems pharmacology in understanding drug adverse events

  2011cited by this paper
• Current standing and future prospects for the technologies proposed to transform toxicity testing in the 21st century.

  2011cited by this paper
• Current standing and future prospects for the technologies proposed to transform toxicity testing in the 21st century.

  2011cited by this paper
• Gender differences in drug toxicity.

  2010cited by this paper
• Survey of the Quality of Experimental Design, Statistical Analysis and Reporting of Research Using Animals

  2009cited by this paper
• Computing normalised prediction distribution errors to evaluate nonlinear mixed-effect models: The npde add-on package for R

  2008cited by this paper
• Gastric mucosal defense and cytoprotection: bench to bedside.

  2008cited by this paper
• Mechanism-based pharmacokinetic-pharmacodynamic (PK-PD) modeling in translational drug research.

  2008cited by this paper
• Conditional Weighted Residuals (CWRES): A Model Diagnostic for the FOCE Method

  2007cited by this paper
• Human Pharmacology of Naproxen Sodium

  2007cited by this paper
• Animal experiments scrutinised: systematic reviews demonstrate poor human clinical and toxicological utility.

  2007cited by this paper
• Diagnosing Model Diagnostics

  2007cited by this paper
• COX-2 in play at the AHA and the FDA.

  2007cited by this paper
• Comparison of treatment effects between animal experiments and clinical trials: systematic review

  2006cited by this paper
• Correlation between in vitro and in vivo concentration–effect relationships of naproxen in rats and healthy volunteers

  2006cited by this paper
• PsN-Toolkit - A collection of computer intensive statistical methods for non-linear mixed effect modeling using NONMEM

  2005cited by this paper
• Mechanism-Based Pharmacokinetic–Pharmacodynamic Modeling—A New Classification of Biomarkers

  2005cited by this paper
• Pharmacokinetic-pharmacodynamic correlations and biomarkers in the development of COX-2 inhibitors.

  2005cited by this paper
• Evidence-based toxicology: a comprehensive framework for causation

  2005cited by this paper
• Can the pharmaceutical industry reduce attrition rates?

  2004cited by this paper
• Simultaneous vs. Sequential Analysis for Population PK/PD Data I: Best-Case Performance

  2003cited by this paper
• Simultaneous vs. Sequential Analysis for Population PK/PD Data II: Robustness of Methods

  2003cited by this paper
• Cyclooxygenase-2 in myocardium stimulation by angiotensin-II in cultured cardiac fibroblasts and role at acute myocardial infarction.

  2002cited by this paper
• Cardiovascular Thrombotic Events in Controlled, Clinical Trials of Rofecoxib

  2001cited by this paper
• Pharmacokinetic/pharmacodynamic modeling of antipyretic and anti-inflammatory effects of naproxen in the rat.

  2001cited by this paper
• Comparison of upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis. VIGOR Study Group.

  2000cited by this paper
• Adverse upper gastrointestinal effects of rofecoxib compared with NSAIDs.

  1999cited by this paper
• Incidence of adverse drug reactions in hospitalized patients: a meta-analysis of prospective studies.

  1998cited by this paper
• High-performance liquid chromatographic determination of ketoprofen and naproxen in rat plasma.

  1988cited by this paper
• Strain differences in aspirin-induced gastric ulceration in rats.

  1978cited by this paper
• Nonlinear plasma level response to high doses of naproxen

  1974cited by this paper
• Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs.

  1971cited by this paper

• NSAIDs Reduce Therapeutic Efficacy of Mesenchymal Stromal Cell Therapy in a Rodent Model of Posttraumatic Osteoarthritis

  2022cites this paper
• Prospective evaluation of cardiovascular safety in early clinical development: a case study with methadone.

  2017cites this paper
• Characterizing QT interval prolongation in early clinical development: a case study with methadone

  2017cites this paper
• Prediction of thyroid C‐cell carcinogenicity after chronic administration of GLP1‐R agonists in rodents

  2017cites this paper
• Reverse engineering of drug induced QT(c) interval prolongation : towards a systems pharmacology approach

  2017cites this paper
• Pharmacology-based toxicity assessment: towards quantitative risk prediction in humans.

  2016cites this paper
• Assessment of Interspecies Differences in Drug-Induced QTc Interval Prolongation in Cynomolgus Monkeys, Dogs and Humans

  2015cites this paper
• Model‐based prediction of the acute and long‐term safety profile of naproxen in rats

  2015cites this paper
• The impact of composite AUC estimates on the prediction of systemic exposure in toxicology experiments

  2015cites this paper
• Estudo dos anti-inflamatórios e analgésicos utilizados pelos idosos da Estratégia Saúde da Família de Porto Alegre

  2014cites this paper